IDH1 and astrocytoma (excluding glioblastoma): To molecularly characterize foci found in DLGG patients (Fig. 1A), we selected 8 tumours with mutations for IDH1 (IDH1 R132H) with and without 1p19q co-deletion (4 oligodendrogliomas and 4 astrocytomas respectively) (Table S1).